학술논문
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours.
Document Type
journal article
Author
Source
British Journal of Cancer; 10/26/2010, Vol. 103 Issue 9, p1362-1368, 7p, 1 Diagram, 4 Charts
Subject
Language
ISSN
00070920
Abstract
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)